Netramark Hldgs Inc (AINMF)

$0.83 +0.07 (9.45%)
Market Cap 73.26M
Revenue (ttm) 340,000.00
Net Income (ttm) -2.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -720.59%
Debt to Equity Ratio 0.00
Volume 4,900
Avg Vol 4,606
Day's Range N/A - N/A
Shares Out 88.59M
Stochastic %K 33%
Beta N/A
Analysts Strong Buy
Price Target $1.65

Company Profile

NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. The company's product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials. It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers i...

Industry: Health Information Services
Sector: Healthcare
Phone: 403 681 2549
Address:
1655 Dupont Street, Suite 101, Toronto, Canada
SmallCapComms
SmallCapComms Nov. 17 at 6:50 PM
$AINMF Just interviewed @NetraMark_AI $AIAI.CN / $AINMF one of the most interesting AI companies in the clinical-trial space. We covered: • Why 60–90% of trials fail • How “personas” can save or rescue Phase 2/3 studies • Their partnership with Worldwide Clinical Trials • FDA meeting coming this December • NIMH collaboration + peer-reviewed publication This company is doing things most AI companies can’t — explainable, regulator-aligned, real-world AI. Not investment advice. I do not own shares and I was not paid. Full interview 👇 🎥 https://youtu.be/Ae2fSzLXUiE?si=97M_4JPbJ1rulwW_
0 · Reply
ZacksSCR
ZacksSCR Aug. 7 at 4:24 PM
$AINMF: Believe Recent Agreements Illustrate Growing Traction of AI Solutions to De-Risk Clinical Research https://buff.ly/nrwUA1n
0 · Reply
ZacksSCR
ZacksSCR Jul. 28 at 5:13 PM
$AINMF: NetraMark aims to solve one of pharma’s biggest challenges: understanding patient variability in trials. CEO George Achilleos explains the company’s unique approach. https://buff.ly/6fXNxqj
0 · Reply
ZacksSCR
ZacksSCR Jul. 11 at 5:10 PM
$AINMF Netramark is an AI company helping pharma companies de-risk clinical trials and increase their efficiency by identifying patient subpopulations that may negatively impact outcomes. https://youtu.be/3KuYLJZUN6o #AI #MachineLearning #ClinicalTrials
1 · Reply
ZacksSCR
ZacksSCR Jul. 1 at 7:22 PM
$AINMF: Solutions to De-Risk Clinical Research Trials Expected to Gain Substantial Traction; Initiating Coverage https://buff.ly/deRmCWd
0 · Reply
Clkrrb
Clkrrb Apr. 4 at 5:13 AM
$AINMF What top 5 pharmaceutical company are they working with?
0 · Reply
katorvix
katorvix Dec. 11 at 8:07 PM
$AINMF 👀
0 · Reply
newsfile_corp
newsfile_corp Oct. 2 at 12:03 PM
https://nfne.ws/225319 $AINMF #CantechLetter #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 27 at 5:28 PM
$AINMF https://www.newswire.ca/news-releases/netramark-signs-two-contracts-with-large-biopharmaceutical-company-to-enhance-clinical-trial-insights-814623532.html
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 20 at 7:01 PM
$AINMF https://www.newswire.ca/news-releases/netramark-signs-two-contracts-with-large-biopharmaceutical-company-to-enhance-clinical-trial-insights-814623532.html#:~:text=NetraMark%20is%20a%20company%20focused,targeted%20at%20the%20Pharmaceutical%20industry.
0 · Reply
Latest News on AINMF
No data available.
SmallCapComms
SmallCapComms Nov. 17 at 6:50 PM
$AINMF Just interviewed @NetraMark_AI $AIAI.CN / $AINMF one of the most interesting AI companies in the clinical-trial space. We covered: • Why 60–90% of trials fail • How “personas” can save or rescue Phase 2/3 studies • Their partnership with Worldwide Clinical Trials • FDA meeting coming this December • NIMH collaboration + peer-reviewed publication This company is doing things most AI companies can’t — explainable, regulator-aligned, real-world AI. Not investment advice. I do not own shares and I was not paid. Full interview 👇 🎥 https://youtu.be/Ae2fSzLXUiE?si=97M_4JPbJ1rulwW_
0 · Reply
ZacksSCR
ZacksSCR Aug. 7 at 4:24 PM
$AINMF: Believe Recent Agreements Illustrate Growing Traction of AI Solutions to De-Risk Clinical Research https://buff.ly/nrwUA1n
0 · Reply
ZacksSCR
ZacksSCR Jul. 28 at 5:13 PM
$AINMF: NetraMark aims to solve one of pharma’s biggest challenges: understanding patient variability in trials. CEO George Achilleos explains the company’s unique approach. https://buff.ly/6fXNxqj
0 · Reply
ZacksSCR
ZacksSCR Jul. 11 at 5:10 PM
$AINMF Netramark is an AI company helping pharma companies de-risk clinical trials and increase their efficiency by identifying patient subpopulations that may negatively impact outcomes. https://youtu.be/3KuYLJZUN6o #AI #MachineLearning #ClinicalTrials
1 · Reply
ZacksSCR
ZacksSCR Jul. 1 at 7:22 PM
$AINMF: Solutions to De-Risk Clinical Research Trials Expected to Gain Substantial Traction; Initiating Coverage https://buff.ly/deRmCWd
0 · Reply
Clkrrb
Clkrrb Apr. 4 at 5:13 AM
$AINMF What top 5 pharmaceutical company are they working with?
0 · Reply
katorvix
katorvix Dec. 11 at 8:07 PM
$AINMF 👀
0 · Reply
newsfile_corp
newsfile_corp Oct. 2 at 12:03 PM
https://nfne.ws/225319 $AINMF #CantechLetter #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 27 at 5:28 PM
$AINMF https://www.newswire.ca/news-releases/netramark-signs-two-contracts-with-large-biopharmaceutical-company-to-enhance-clinical-trial-insights-814623532.html
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 20 at 7:01 PM
$AINMF https://www.newswire.ca/news-releases/netramark-signs-two-contracts-with-large-biopharmaceutical-company-to-enhance-clinical-trial-insights-814623532.html#:~:text=NetraMark%20is%20a%20company%20focused,targeted%20at%20the%20Pharmaceutical%20industry.
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 5 at 11:34 PM
$AINMF $GME $AMC $KOSS .27 cents a share small float, AI + expediting clinical trial drugs big risk big reward get some
0 · Reply
Jpetersonlions
Jpetersonlions Dec. 5 at 10:41 PM
$AINMF LETS GO BABY
0 · Reply
fla
fla May. 16 at 12:15 PM
$AINMF [15s. delayed]: Issued Press Release on May 16, 08:15:00: NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKIN https://s.flashalert.me/veSvv
0 · Reply
Stock_Titan
Stock_Titan May. 16 at 12:15 PM
$AINMF NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKING TECHNOLOGY THAT INTEGRATES CHATGPT https://www.stocktitan.net/news/AINMF/netramark-the-first-public-ai-company-to-launch-clinical-trial-de-fuoqldvygd9v.html #clinicaltrial
0 · Reply